SI
Surebion, Inc.
SEC filingBiotechnology · Los Angeles, CA
Amount raised$35sold at filing
Total offering$35
Investors in the raise5count reported to the SEC
FiledSep 5, 2025first sale Aug 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Susanne NichalasDirector
Stephen Paul RothmanExecutive Officer
Robert DamoiseauxDirector
Troy BarringExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.